Moderna says potential flu vaccine wants extra research
Moderna shares slipped Tuesday morning after the COVID-19 vaccine developer mentioned its potential flu vaccine wants extra research in a late-stage scientific trial.
The firm mentioned an impartial information and security monitory board discovered that the potential vaccine “did not meet the statistical ...